![[Search]](/static/images/search.gif){kind=small}
![[A-Z Index]](/static/images/az.gif){kind=small}
![[Contact]](/static/images/contact.gif){kind=small}
![[University of Cambridge]](/static/images/identifier2.gif){kind=small}
![[Talks.cam]](/static/images/talkslogosmall.gif)
Darren Cross, Richard A Ward, Ray Finlay (AstraZeneca Oncology Innovative Medicines)
Friday 16 October 2015, 16:00-17:30
Inhibition of EGF receptor signalling: The Discovery of AZD9291
- đ¤ Speaker: Darren Cross, Richard A Ward, Ray Finlay (AstraZeneca Oncology Innovative Medicines)
- đ Date & Time: Friday 16 October 2015, 16:00 - 17:30
- đ Venue: Department of Pharmacology Lecture Theatre, Tennis Court Road
Questions? Contact
Dr Matthew Harper
Abstract
Abstract not available
Series This talk is part of the Pharmacology Tea Club Michaelmas 2015 series.
Included in Lists
- Department of Pharmacology Lecture Theatre, Tennis Court Road
- Department of Pharmacology Lecture Theatre, Tennis Court Road
Note: Ex-directory lists are not shown.